Patients in phase 1 cancer trials: psychological distress and understanding of trial information

References

• Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–174.
   PubMed Web of Science ®Google Scholar
• Tomamichel M, Jaime H, Degrate A, et al. Proposing phase I studies: patients’, relatives’, nurses’ and specialists’ perceptions. Ann Oncol. 2000;11(3):289–294.
   PubMed Web of Science ®Google Scholar
• Cohen L, de Moor C, Amato RJ. The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a phase I cancer clinical trial. Cancer. 2001;91(10):1949–1955.
   PubMed Web of Science ®Google Scholar
• Catt S, Langridge C, Fallowfield L, et al. Reasons given by patients for participating, or not, in phase 1 cancer trials. Eur J Cancer. 2011;47(10):1490–1497.
   PubMed Web of Science ®Google Scholar
• Rouanne M, Massard C, Hollebecque A, et al. Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a phase i clinical trial unit of predominantly targeted anticancer drugs. Eur J Cancer. 2013;49(2):431–438.
   PubMed Web of Science ®Google Scholar
• Dunn LB, Wiley J, Garrett S, et al. Interest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients. Psychooncology. 2017;26(10):1604–1610.
   PubMed Web of Science ®Google Scholar
• Kreitler S, Peleg D, Ehrenfeld M. Stress, self-efficacy and quality of life in cancer patients. Psychooncology. 2007;16(4):329–341.
   PubMed Web of Science ®Google Scholar
• Cook N, Hansen AR, Siu LL, et al. Early phase clinical trials to identify optimal dosing and safety. Mol Oncol. 2015;9(5):997–1007.
   PubMed Web of Science ®Google Scholar
• Gad KT, Lassen U, Mau-Sørensen M, et al. Patient information in phase I trials: a systematic review. Psychooncology. 2018;27(3):768–780.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, Von Elm E, Altman DG, for the STROBE Initiative, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLOS Med. 2007;4(10):e297–1654.
   PubMed Web of Science ®Google Scholar
• Kocalevent RD, Hinz A, Brähler E. Standardization of the depression screener patient health questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2013;35(5):551–555.
   PubMed Web of Science ®Google Scholar
• Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Heal Soc Behav. 1983;24(4):385–396.
   PubMed Web of Science ®Google Scholar
• Cohen S, Williamson GM. Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, editors. The social psychology of health: Claremont Symposium on Applied Social Psychology. Newbury Park (CA): Sage; 1988. p. 31–67.
   Google Scholar
• Eskildsen A, Dalgaard VL, Nielsen KJ, et al. Cross-cultural adaptation and validation of the danish consensus version of the 10-item perceived stress scale. Scand J Work Environ Health. 2015;41(5):486–490.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097.
   PubMed Web of Science ®Google Scholar
• Spitzer RL. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Jama. 1999;282(18):1737.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
   PubMed Web of Science ®Google Scholar
• Joffe S, Cook E, Cleary P, et al. Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst. 2001;93(2):139–147.
   PubMed Web of Science ®Google Scholar
• Nordin M, Nordin S. Psychometric evaluation and normative data of the Swedish version of the 10-item perceived stress scale. Scand J Psychol. 2013;54(6):502–507.
   PubMed Web of Science ®Google Scholar
• Löwe B, Decker O, Müller S, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46(3):266–274.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World medical association declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194.
   PubMed Web of Science ®Google Scholar
• Gad KT, Johansen C, Duun-Henriksen AK, et al. Socioeconomic differences in referral to phase I cancer clinical trials: a Danish matched cancer case-control study. J Clin Oncol. 2019;37(13):1111–1119.
   PubMed Web of Science ®Google Scholar
• Kreiberg M, Bandak M, Lauritsen J, et al. Psychological stress in long-term testicular cancer survivors: a danish nationwide cohort study. J Cancer Surviv. 2020;14(1):72–79.
   PubMed Web of Science ®Google Scholar
• Golden-Kreutz DM, Browne MW, Frierson GM, et al. Assessing stress in cancer patients: a second-order factor analysis model for the perceived stress scale. Assessment. 2004;11(3):216–223.
   PubMed Web of Science ®Google Scholar
• Dalton SO, Laursen TM, Ross L, et al. Risk for hospitalization with depression after a cancer diagnosis: a nationwide, population-based study of cancer patients in Denmark from 1973 to 2003. J Clin Oncol. 2009;27(9):1440–1445.
   PubMed Web of Science ®Google Scholar
• Joffe S, Cook EF, Cleary PD, et al. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001;358(9295):1772–1777.
   PubMed Web of Science ®Google Scholar
• Jefford M, Mileshkin L, Matthews J, et al. Satisfaction with the decision to participate in cancer clinical trials is high, but understanding is a problem. Support Care Cancer. 2011;19:371–379.
   PubMed Web of Science ®Google Scholar
• Schumacher A, Sikov WM, Quesenberry MI, et al. Informed consent in oncology clinical trials: a brown university oncology research group prospective cross-sectional pilot study. PLOS One. 2017;12(2):e0172957–13.
   PubMed Web of Science ®Google Scholar
• Bergenmar M, Molin C, Wilking N, et al. Knowledge and understanding among cancer patients consenting to participate in clinical trials. Eur J Cancer. 2008;44(17):2627–2633.
   PubMed Web of Science ®Google Scholar
• Adashek JJ, LoRusso PM, Hong DS, et al. Phase I trials as valid therapeutic options for patients with cancer. Nat Rev Clin Oncol. 2019;16(12):773–778.
   PubMed Web of Science ®Google Scholar
• Weber JS, Levit LA, Adamson PC, et al. American society of clinical oncology policy statement update: the critical role of phase I trials in cancer research and treatment. J Clin Oncol. 2015;33(3):278–284.
   PubMed Web of Science ®Google Scholar
• Weber JS, Levit LA, Adamson PC, et al. Reaffirming and clarifying the American Society of Clinical Oncology's policy statement on the critical role of phase I trials in cancer research and treatment. J Clin Oncol. 2017;35(2):139–140.
   PubMed Web of Science ®Google Scholar
• Schwaederle M, Zhao M, Lee JJ, et al. Association of biomarker-based treatment strategies with response rates and progression-free survival in refractory malignant neoplasms. JAMA Oncol. 2016;2(11):1452–1458.
   PubMed Web of Science ®Google Scholar
• Tuxen IV, Rohrberg KS, Oestrup O, et al. Copenhagen prospective personalized oncology (CoPPO)-clinical utility of using molecular profiling to select patients to phase I trials. Clin Cancer Res. 2019;25(4):1239–1247.
   PubMed Web of Science ®Google Scholar
• Chakiba C, Grellety T, Bellera C, et al. Encouraging trends in modern phase 1 oncology trials. N Engl J Med. 2018;378(23):2242–2243.
   PubMed Web of Science ®Google Scholar